![](/img/cover-not-exists.png)
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes
Cavo, Alessia, Rubagotti, Alessandra, Zanardi, Elisa, Fabbroni, Chiara, Zinoli, Linda, Di Meglio, Antonio, Arboscello, Eleonora, Bellodi, Andrea, Spallarossa, Paolo, Cattrini, Carlo, Messina, Carlo, BVolume:
10
Language:
english
Journal:
Therapeutic Advances in Medical Oncology
DOI:
10.1177/1758834017745819
Date:
January, 2018
File:
PDF, 192 KB
english, 2018